Skip to content
MS
ARSA AR unreviewed

Metachromatic leukodystrophy

Enzyme or protein defect

Arylsulfatase A

Accumulates or becomes deficient

Cerebroside sulfate

Key features

Central and peripheral demyelination, ataxia, dementia

Management

HSCT / gene therapy in early disease

Not clinical guidance. Written from standard clinical biochemistry, not from the uploaded documents, and marked unreviewed. Teaching-level reference for study and database seeding only. It must not be used to manage a patient.

Recent literature

Europe PMC · fetched just now · sorted by publication date

  1. 1
  2. 2
    Reframing the value of reserve antibiotics: how ultra-orphan reimbursement pathways could offer fair and equitable access to new antibiotics.

    Quinn J, Amersdorffer J, Boysen M, Duffy-Roger O, Hewitt C, Jain M, McKinney D, Ivezic-Schoenfeld Z, Toumi M,… · 2026-07-17

    open access unreviewed
  3. 3
  4. 4
    Proteomic Signatures of Noise-Induced Hearing Loss in the Mouse Cochlea.

    Batissoco AC, Alencar-Coutinho D, Ferreira-Scatone AC, Diogo-Cavassana S, Oiticica J, Lezirovitz K, Bento RF. · 2026-10-01

    open access unreviewed
  5. 5
  6. 6
  7. 7
  8. 8
    Characterization of hematopoietic stem cell-derived microglia-like cells in nonhuman primates.

    Petty NE, Wolf CB, Kanestrom G, Mendoza M, Swing K, Murnane R, Tong A, Starrs M, Fields E, Madhu R, Nelson V,… · 2026-10-01

    open access unreviewed
  9. 9
  10. 10
    A review of genetic modification for ex vivo cellular therapies.

    Dinh A, Zhang N, Stroncek D. · 2026-09-01

    open access unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.